Skip to Content

Biosimilar Antibodies


Gentaur supplies research-grade biosimilar antibodies designed for non-clinical studies that mirror the structure and function of FDA-approved biologics. These antibodies include equivalents to Adalimumab, Nivolumab, Trastuzumab, Rituximab, Palivizumab, and more. Each product is validated by ELISA, FCM, functional assays, and tested for high-affinity target binding (e.g., TNFα, PD-1, HER2, RSV). Ideal for mechanistic studies, antibody engineering, and immune modulation assays.
Key targets: TNFα, PD-1, IL4RA, ERBB2, RSV, STEAP1, APP, IL31RA, IL12B
1,234,567.00 1234567.0 USD
1,234,567.00 1234567.0 USD
1,234,567.00 1234567.0 USD
1,234,567.00 1234567.0 USD
1,234,567.00 1234567.0 USD
1,234,567.00 1234567.0 USD
1,234,567.00 1234567.0 USD
1,234,567.00 1234567.0 USD
1,234,567.00 1234567.0 USD

Our latest content

Check out what's new in our company !

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.